Research News

Jing Shi | Department of Mechanical and Materials Engineering

This study aimed to evaluate the association between N-acetyltransferase 2 (NAT2) gene polymorphisms and the risk of antituberculosis drug-induced liver injury (ATLI). Materials & methods: A meta-analysis was performed including 27 studies with 1289 cases and 5462 controls. Odds ratio with 95% CI was used to evaluate the strength of association. Results: Our meta-analysis found that NAT2 slow acetylators were associated with increased risk of ATLI compared with fast and intermediate acetylators when standard dose of isoniazid was administrated (odds ratio: 3.08; 95% CI: 2.29-4.15). Conclusion: Individuals with NAT2 slow acetylators may have increased risk of ATLI when standard dose of isoniazid was used. Detection of NAT2 genotype may benefit to the prevention of ATLI.


Cited from Dr. Shi's Publication, "Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: A meta-analysis"


Select for more information about the research activities within the College of Engineering and Applied Science.